Seer Inc SEER

US Life Sciences Tools & Services

$1.91 ▲ +2.14% (+$0.04)

⬆️ Above Yest. High

Open $1.88

Prev Close $1.87

Day Range $1.87 – $1.96

52W Range $1.55 – $2.41

Market Cap $105.76M

Beta 1.49

EPS (TTM) $-1.22

📋 Company Profile

Industry	Life Sciences Tools & Services
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-12-04
Shares Out.	54,980,000
Website	seer.bio/ ↗
Phone	16504530000
Employees	124
Revenue	$3.1M
Gross Profit	$1.5M
Net Income	-$16.9M
Free Cash Flow	-$44.2M
Total Assets	$256.6M
Total Liabilities	$31.0M
Equity	$225.7M

About Seer Inc

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Seer Inc is a publicly traded company under the ticker symbol SEER on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.